If MAC lists were not in place, prices for drugs would vary dramatically. Discounts for generic drugs would also decrease significantly.
Brent J. Eberle, RPh
Advertisement
Eberle is vice president of industry relations and specialty pharmacy at Navitus Health Solutions.
Articles by Brent J. Eberle, RPh
Advertisement
Latest Updated Articles
- Your PBM's MAC list impacts your bottom line
Published: December 1st 2008 | Updated:
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
The FDA proposes ditching comparative efficacy studies for biosimilars
2
How new psoriasis, alopecia and atopic dermatitis therapies stood out at Fall Clinical Derm 2025
3
Phase 3 trial launches for novel antibody targeting integrin beta-6 in advanced lung cancer
4
UC Davis develops new drug for bladder cancer patients
5